🎬 Nolan's Odyssey Crushes Box Office Records 🚀

Christopher Nolan's epic, The Odyssey, is dominating the North American box office by hitting its fifth week. The film, starring Matt Damon, currently holds the #2 spot behind Spider-Man: Brand New Day. It earned $3.8 million on its fifth Monday, bringing its total collection to $508.9 million. This performance makes it the biggest fifth Monday for R-Rated films and Nolan's career. The Odyssey is projected to end its run near $550 million, aiming for the top 20 US grossers.

🧠 Citicoline might boost motor function in Parkinson's patients

A trial investigated if adding citicoline could improve motor function in Parkinson's disease patients. The study took place across 44 Italian clinics, involving 474 individuals aged 55 or older. Over 24 weeks, the citicoline group (n=303) was compared to the placebo group (n=171). While the overall score wasn't significantly different, the mITT group showed better motor function improvement with citicoline. Investigators suggest citicoline could offer benefits for those with high treatment adherence. 🧠

🧠 New online tool helps manage bipolar disorder treatments

A new online tool, EBI-BD, has compiled the best evidence on bipolar disorder treatments for clinicians and patients. This platform was developed by researchers to synthesize findings across various age groups and mood phases. The review analyzed 77 meta-analyses covering 116 unique treatments and 2510 comparisons, published on August 11 in The BMJ. It offers a preference-based tool allowing users to weigh benefits against side effects for informed decisions. The authors plan to update this 'living' review at least every two years. 🧠

🔬 Prostate cancer watch vs. focal therapy trends

Active surveillance rates are significantly increasing among US veterans with low-risk prostate cancer, according to VA data. Meanwhile, over 15,000 patients received focal therapy between 2010 and 2023 nationally. This trend is notable because focal therapy currently lacks strong, high-quality supporting evidence. The studies, published on August 13 in JAMA, highlight progress in surveillance but raise concerns about focal therapy use. Future focus will be on solidifying evidence for these treatment modalities. 🧐

🧪 Smart gel switches states for drug delivery

Scientists at the University of Birmingham developed a multi-responsive gel platform using foldamers. This material can switch between gel and liquid states in response to UV light, heat, and acid. The research, published in the Journal of the American Chemical Society, details how these synthetic molecules self-assemble and disassemble. This advancement could significantly guide the development of targeted drug delivery systems for specific conditions. Future applications include smart sensors and controlled release of therapeutic molecules. 🔬

🎬 DC slows down as 'Vishwanath & Sons' takes over

Lokesh Kanagaraj's acting debut, DC, is facing a slowdown in its second week at the box office. The film is currently competing with the new release, Vishwanath & Sons, starring Suriya in Tamil Nadu. As of Day 12, DC's net domestic collection is 58.57 crore and worldwide gross stands at 90.61 crore. The competition means DC might miss the 100 crore milestone domestically and could end its run under 70 crore. The film is expected to wrap as the 4th-highest-grossing Tamil film of the year. 📉

🔬 Caffeine metabolite might slow kids' nearsightedness

Researchers are exploring 7-methylxanthine (7-MX) as a potential treatment to slow down childhood myopia progression. The study focuses on how 7-MX targets scleral remodeling and axial elongation in children. A 36-month pilot study involving 68 myopic children showed reduced axial growth with no adverse effects reported. This drug acts by promoting structural reinforcement in the eye's back, stimulating collagen production. The findings suggest 7-MX could complement current myopia control strategies for better long-term eye health. 🔬

🍅 Tomatoes might help cut liver fat for MASLD patients

Eating raw tomatoes and tomato sauce daily was shown to lower the risk of hepatic steatosis in a small trial. This study was conducted on 79 adults with MASLD at a center in Bari, Italy. The intervention group ate 200g of raw tomatoes and 50g of sauce daily for six weeks. CAP decreased significantly more in the tomato group compared to the control group. These findings suggest tomato consumption could reduce liver fat independently of major body weight changes.

🤝 VCK pledges support to TVK for full term

Thol. Thirumavalavan stated that VCK will back the state government to complete its full term. He met Chief Minister C. Joseph Vijay on his 100-day mark to assure this support. This commitment comes after VCK supported TVK in forming the government and secured a cabinet position. Thirumavalavan urged the CM to fight for Tamil rights and focus on caste and drug issues. A follow-up meeting is scheduled after the upcoming assembly session.

🚧 Vellore Corporation clears encroachments on Arcot Road

Vellore Corporation demolished several temporary structures and shop extensions on the congested Arcot Road near CMC Hospital on Tuesday. The operation targeted commercial buildings to restore the original road width and ease vehicle movement, especially for ambulances. A total of 60 structures were brought down, which will create 15 to 40 feet of extra road space. This action aligns with the plan to ensure road user safety, given the high foot traffic to the hospitals. The demolition drive, ordered by Collector P.S. Leela Alex, will continue as a process. 🚧

🚀 SpaceX Rocket Hits Moon, NASA Spots Strange Scars

A SpaceX rocket made impact with the Moon recently. NASA confirmed the landing site was near a specific crater on the lunar surface. The event occurred with data gathered on [Date - assumed missing but must be kept as per rule, so I will state the fact of the discovery]. Researchers observed unusual 'butterfly' shaped scars surrounding the impact zone. Scientists are now studying these formations to better understand the impact dynamics. 🛰️